Email this article Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients withtype 2 diabetes mellitus and mild hypertension:a sequential, randomized, double-blind clinical trial
- Authors: Giuseppe Derosa -1, Arrigo FG Cicero -1, Angela D'Angelo -1, Elena Fogari -1, Sibilla Salvadeo -1, Alessia Gravina -1, Ilaria Ferrari -1, Raffaella Fassi -1, Roberto Fogari -1
-
Affiliations:
- Issue: Vol 6, No 1 (2009)
- Pages: 54-58
- Section: Articles
- URL: https://journals.eco-vector.com/2075-082X/article/view/33066
- DOI: https://doi.org/10.26442/SG33066
- ID: 33066
Cite item
Full Text
Abstract
Keywords
About the authors
- Giuseppe Derosa
- Arrigo FG Cicero
- Angela D'Angelo
- Elena Fogari
- Sibilla Salvadeo
- Alessia Gravina
- Ilaria Ferrari
- Raffaella Fassi
- Roberto Fogari
Supplementary files
